Karyopharm Therapeutics Stock Technical Analysis
| KPTI Stock | USD 0.62 0.02 3.72% |
As of the 23rd of December, Karyopharm Therapeutics secures the Mean Deviation of 3.06, risk adjusted performance of (0.01), and Standard Deviation of 4.86. Karyopharm Therapeutics technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.
Karyopharm Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Karyopharm, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to KaryopharmKaryopharm |
Karyopharm Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 6.67 | Strong Buy | 7 | Odds |
Most Karyopharm analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Karyopharm stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Karyopharm Therapeutics, talking to its executives and customers, or listening to Karyopharm conference calls.
Karyopharm Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Karyopharm Therapeutics Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Karyopharm Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Karyopharm Therapeutics Trend Analysis
Use this graph to draw trend lines for Karyopharm Therapeutics. You can use it to identify possible trend reversals for Karyopharm Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Karyopharm Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Karyopharm Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Karyopharm Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.0031 , which may suggest that Karyopharm Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.37, which is the sum of squared deviations for the predicted Karyopharm Therapeutics price change compared to its average price change.About Karyopharm Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Karyopharm Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Karyopharm Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Karyopharm Therapeutics price pattern first instead of the macroeconomic environment surrounding Karyopharm Therapeutics. By analyzing Karyopharm Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Karyopharm Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Karyopharm Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 2.12 | 1.88 | 1.58 | 1.5 | Days Of Inventory On Hand | 440.53 | 295.75 | 224.75 | 219.24 |
Karyopharm Therapeutics December 23, 2024 Technical Indicators
Most technical analysis of Karyopharm help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Karyopharm from various momentum indicators to cycle indicators. When you analyze Karyopharm charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.14) | |||
| Mean Deviation | 3.06 | |||
| Coefficient Of Variation | (4,473) | |||
| Standard Deviation | 4.86 | |||
| Variance | 23.63 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.25) | |||
| Treynor Ratio | (0.15) | |||
| Maximum Drawdown | 26.95 | |||
| Value At Risk | (5.56) | |||
| Potential Upside | 8.97 | |||
| Skewness | 1.71 | |||
| Kurtosis | 4.66 |
Complementary Tools for Karyopharm Stock analysis
When running Karyopharm Therapeutics' price analysis, check to measure Karyopharm Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Karyopharm Therapeutics is operating at the current time. Most of Karyopharm Therapeutics' value examination focuses on studying past and present price action to predict the probability of Karyopharm Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Karyopharm Therapeutics' price. Additionally, you may evaluate how the addition of Karyopharm Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |